EDITORIAL
Editorial: Focus feature on biomarkers
in network neuroscience
Linda Douw1, Mario Senden2,3, and Martijn van den Heuvel4,5
1Department of Anatomy and Neurosciences, Amsterdam Neuroscience, UMC, Vrije
Universiteit Amsterdam, Amsterdam, Netherlands
2Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience,
Maastricht University, Maastricht, Netherlands
3Maastricht Brain Imaging Centre, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands
4Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research,
Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, Netherlands
5Department of Child Psychiatry, Amsterdam UMC, Vrije
Universiteit Amsterdam, Amsterdam, Netherlands
Mots clés: Clinical neuroscience, Neurologie, Psychiatry, Graph theory, Connectome, Treatment
monitoring, Response prediction, Personalized medicine, Precision medicine
je
D
o
w
n
o
un
d
e
d
F
r
o
m
h
t
t
p
:
/
/
d
je
r
e
c
t
.
m
je
t
.
t
/
/
e
d
toi
n
e
n
un
r
t
je
c
e
–
p
d
je
F
/
/
/
/
/
6
2
2
9
8
2
0
2
8
1
4
7
n
e
n
_
e
_
0
0
2
4
9
p
d
.
t
F
b
oui
g
toi
e
s
t
t
o
n
0
7
S
e
p
e
m
b
e
r
2
0
2
3
ABSTRAIT
There is an ongoing need for novel biomarkers in clinical neuroscience, as diagnosis of
neurological and psychiatric disorders is hampered by the pronounced overlap of behavioral
symptoms and other pathophysiological characteristics. The question that this Focus Feature
puts center stage is whether network-based biomarkers may provide a viable tool for
distinguishing between disordered populations or whether they may yield only limited
differentiating power because of largely shared network characteristics across conditions.
Multiple approaches exist to address the question of whether network-based biomarkers may
have clinical utility; we explore many of these in this Focus Feature. Blomsma and colleagues
(Blomsma et al., 2022) focus on the minimum spanning tree (MST) as a tool that potentially
unearths differences between neurological or psychiatric pathologies and healthy controls.
The authors propose that the MST offers a theoretical approach towards thresholding adja-
cency matrices, by including the subset of edges that maximize connectivity while not forming
any loops or cycles. They perform a systematic review on MST studies using different network
sizes and assess disease specificity and transdiagnostic sensitivity of MST-based metrics.
Although contradictions were present in results across studies, several trends could neverthe-
less be distilled within and across disease categories. Fait intéressant, it became clear that the
MST measure of leaf fraction depends on network size independent of disease population,
limiting the interpretability of this measure across studies with different methodologies. Le
authors also suggest that reporting guidelines are needed in network neuroscience, emphasi-
zing the importance of always reporting numeric values for network metrics as well as the
analysis tools used as completely as possible.
The work by Rodriguez-Cruces and colleagues (Rodriguez-Cruces et al., 2022) uses a dif-
ferent strategy towards biomarker exploration: They reviewed the current state of network neu-
roscience literature in three particular epilepsy syndromes that are difficult to differentiate,
with the hope to identify shared as well as syndrome-specific network substrates. En effet,
the authors conclude that “brain network measures may ultimately serve as powerful
un accès ouvert
journal
Citation: Douw, L., Senden, M., & van
den Heuvel, M.. (2022). Editorial: Focus
feature on biomarkers in network
neuroscience. Neurosciences en réseau,
6(2), 298–300. https://est ce que je.org/10.1162
/netn_e_00249
EST CE QUE JE:
https://doi.org/10.1162/netn_e_00249
Reçu: 4 Avril 2022
Intérêts concurrents: Les auteurs ont
a déclaré qu'aucun intérêt concurrent
exister.
Auteur correspondant:
Linda Douw
l.douw@amsterdamumc.nl
Handlng Editor:
Olaf Sporns
droits d'auteur: © 2022
Massachusetts Institute of Technology
Publié sous Creative Commons
Attribution 4.0 International
(CC PAR 4.0) Licence
La presse du MIT
Editorial
intermediary phenotypes to study effects of biological as well as environmental factors on cog-
nitive systems in epileptic patients, including medication effects, disease status, and baseline
genetic factors,” indicating that there are indeed common and specific network markers for
these syndromes. They recommend future work to incorporate not only multimodal imaging,
but also genetic testing as well as rigorous clinical phenotyping. Together with multisite data
collection, the authors posit that such work could pave the way towards incorporation of
network-based biomarkers in clinical practice in epilepsy.
This Focus Feature also provides and evaluates new network-based biomarkers. Kulik and
colleagues (Kulik et al., 2022) explore associations between structural and functional connec-
tivity in a cohort of multiple sclerosis (MS) patients, and investigate whether (alterations in) ce
relation could be a useful biomarker for cognitive impairment in MS. Although there were
significant differences in structure-function coupling between cognitively impaired patients
and matched healthy controls, receiver operating characteristic (ROC) curves revealed that
these group-level differences did not significantly differentiate between groups. Ce résultat
underlines the importance of reporting classification accuracy for potential biomarkers, partic-
ularly in the context of significant group differences.
Iraji and colleagues (Iraji et al., 2022) use the newly defined method of multiscale indepen-
dent component analysis (msICA) to study shared and specific connectivity patterns across
males and females in schizophrenia. This method allows for data-driven natural detection
of functional sources across different spatial scales. Using three large cohorts, the authors
report on shared network differences between male and female schizophrenic patients, mais
also reveal sex-specific effects that correlated with symptom scores. The authors emphasize
the importance of carefully incorporating sex in the development of diagnostic, predictive,
and/or monitoring biomarkers in schizophrenia.
Enfin, Scheijbeler and colleagues (Scheijbeler et al., 2022) introduce a network version of
permutation entropy as a novel biomarker for early-stage Alzheimer’s disease (AD). This mea-
sure integrates information on local signal variability and complexity with nonlinear coupling.
They indeed find group differences between patients with early AD and a control population.
De plus, classification accuracy through ROC curve analysis was comparable to the current
state-of-the-art biomarker in this context, namely relative theta power. Future work may aim to
replicate this finding in larger samples.
There is promise for network-based biomarkers in clinical neuroscience. An important step
towards adequate investigation of brain network measures as biomarkers is to consistently
report reliability, reproducibility, sensitivity, and specificity of such measures. The increasing
availability of large databases with multimodal data in order to crosslink different approaches
will aid development of biomarkers suitable for differential diagnosis and prognosis. Nous
hope that the work included in this Focus Feature may inform future studies into this impor-
tant topic.
RÉFÉRENCES
Blomsma, N., de Rooy, B., Gerritse, F., van der Spek, R., Tewarie,
P., Hillebrand, UN., … van Dellen, E. (2022). Minimum spanning
tree analysis of brain networks: A systematic review of network
size effects, sensitivity for neuropsychiatric pathology and disor-
der specificity. Neurosciences en réseau, 6(2), 301–319. https://est ce que je
.org/10.1162/netn_a_00245
Iraji, UN., Faghiri, UN., Fu, Z., Rachakonda, S., Kochunov, P., Belger,
UN., … Calhoun, V. D. (2022). Multispatial-scale dynamic
interactions between functional sources reveal sex-specific
changes in schizophrenia. Neurosciences en réseau, 6(2), 357–381.
https://doi.org/10.1162/netn_a_00196
Kulik, S. D., Nauta, je. M., Tewarie, P., Koubiyr, JE., van Dellen, E.,
Ruet, UN., … Schoonheim, M.. M.. (2022). Structure-function
coupling as a correlate and potential biomarker of cognitive
impairment in multiple sclerosis. Neurosciences en réseau, 6(2),
339–356. https://doi.org/10.1162/netn_a_00226
Neurosciences en réseau
299
je
D
o
w
n
o
un
d
e
d
F
r
o
m
h
t
t
p
:
/
/
d
je
r
e
c
t
.
m
je
t
.
/
/
t
e
d
toi
n
e
n
un
r
t
je
c
e
–
p
d
je
F
/
/
/
/
/
6
2
2
9
8
2
0
2
8
1
4
7
n
e
n
_
e
_
0
0
2
4
9
p
d
.
t
F
b
oui
g
toi
e
s
t
t
o
n
0
7
S
e
p
e
m
b
e
r
2
0
2
3
Editorial
Rodriguez-Cruces, R., Royer, J., Larivière, S., Bassett, D. S.,
Caciagli, L., & Bernhardt, B. C. (2022). Multimodal connectome
biomarkers of cognitive and affective dysfunction in the common
epilepsies. Neurosciences en réseau, 6(2), 320–338. https://doi.org
/10.1162/netn_a_00237
Scheijbeler, E. P., van Nifterick, UN. M., Stam, C. J., Hillebrand, UN.,
Gouw, UN. UN., & de Haan, W. (2022). Network-level permutation
entropy of resting-state MEG recordings: A novel biomarker for
early-stage Alzheimer’s disease? Neurosciences en réseau, 6(2),
382–400. https://doi.org/10.1162/netn_a_00224
je
D
o
w
n
o
un
d
e
d
F
r
o
m
h
t
t
p
:
/
/
d
je
r
e
c
t
.
m
je
t
.
/
t
/
e
d
toi
n
e
n
un
r
t
je
c
e
–
p
d
je
F
/
/
/
/
/
6
2
2
9
8
2
0
2
8
1
4
7
n
e
n
_
e
_
0
0
2
4
9
p
d
t
.
F
b
oui
g
toi
e
s
t
t
o
n
0
7
S
e
p
e
m
b
e
r
2
0
2
3
Neurosciences en réseau
300
